Identification of Small Molecule Ligands with NGF Potentiating Activity

具有 NGF 增强活性的小分子配体的鉴定

基本信息

  • 批准号:
    7288985
  • 负责人:
  • 金额:
    $ 10.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-24 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The specific aims of the research described in this application are to develop novel potent and selective small molecule potentiators of NGF dependent activity in neurons, and to characterize their mechanisms of action in promoting neuronal differentiation and survival with regard to new pathways and cellular targets. The objectives in the long term are to develop invaluable tools to better understand the general mechanisms of activity potentiation and the roles of NGF in fostering the development of neural processes. Identified leads with acceptable therapeutic profiles will progress through SAR with the ultimate goal to develop therapeutic agents that prevent or delay the onset of neurodegeneration caused by defects in molecular and chemical cues that initiate and sustain neurite extension. This research will utilize the approaches of chemo-informatics and HTS to identify novel structures and molecules with core chemical scaffolds that are similar to known potentiators of NGF-dependent neurite extension of natural products origin from a chemical library of small molecules. Active compounds will be characterized for potency, efficacy, selectivity, and specificity in neuronal cell lineages to identify lead compounds. Studies on the mechanism of action of lead compounds will be initiated to establish novel pathways and cellular targets that interact with identified leads. Successful development of NGF potentiators with therapeutic values will have a tremendous impact in modifying the outcome of age-related neurodegenerative diseases and other dementias.
描述(由申请人提供):本申请中描述的研究的具体目的是开发NGF依赖性活性的新型和选择性的小分子增强剂,并表征其在促进新途径和细胞靶标方面促进神经元分化和存活方面的作用机制。从长远来看,目标是开发宝贵的工具,以更好地了解活动增强的一般机制以及NGF在促进神经过程发展中的作用。确定的具有可接受的治疗特征的铅将通过SAR进行,其最终目标是开发治疗剂,以防止或延迟由启动和维持神经扩展的分子和化学线索缺陷引起的神经变性的发作。这项研究将利用化学信息学和HTS的方法来鉴定具有核心化学支架的新型结构和分子,这些结构与NGF依赖性神经产物的已知增强剂相似,自然产物的神经产物延伸来自小分子的化学文库。活性化合物将以神经元细胞谱系中的效力,功效,选择性和特异性为特征,以鉴定铅化合物。将启动有关铅化合物作用机理的研究,以建立与已识别铅相互作用的新型途径和细胞靶标。成功开发具有治疗价值的NGF增强剂将对改变与年龄相关的神经退行性疾病和其他痴呆症的结果产生巨大影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Gordon C Ibeanu的其他基金

Identification and confirmation of blood-brain barrier (BBB) permeability of chemical enhancers of nerve growth factor-dependent neurite outgrowth.
神经生长因子依赖性神经突生长的化学增强剂的血脑屏障(BBB)渗透性的鉴定和确认。
  • 批准号:
    9211354
    9211354
  • 财政年份:
    2016
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Identification of Small Molecule Ligands with NGF Potentiating Activity
具有 NGF 增强活性的小分子配体的鉴定
  • 批准号:
    7903839
    7903839
  • 财政年份:
    2009
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Identification of Small Molecule Ligands with NGF Potentiating Activity
具有 NGF 增强活性的小分子配体的鉴定
  • 批准号:
    7500069
    7500069
  • 财政年份:
    2007
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Identification of Small Molecule Ligands with NGF Potentiating Activity
具有 NGF 增强活性的小分子配体的鉴定
  • 批准号:
    7916674
    7916674
  • 财政年份:
    2007
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Identification of Small Molecule Ligands with NGF Potentiating Activity
具有 NGF 增强活性的小分子配体的鉴定
  • 批准号:
    7683033
    7683033
  • 财政年份:
    2007
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
开发用于常规生成正交 GPCR 靶向纳米抗体的集成管道
  • 批准号:
    10603669
    10603669
  • 财政年份:
    2023
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function
阿尔茨海默病和唐氏综合症中 APP 拷贝数变异对 Reelin 表达和功能的影响
  • 批准号:
    10760161
    10760161
  • 财政年份:
    2023
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别: